期刊文献+

热带太平洋深海微生物抗肿瘤活性的初步研究 被引量:3

A Primary Study on Antitumor Activity of Deep-sea Microorganisms Isolated from the Tropical Pacific Ocean
下载PDF
导出
摘要 以4个人体癌细胞株为模型、利用四甲基偶氮唑盐(methyl thiazolyl blue tetrazolium bromide,MTT)比色法和磺酰罗丹明(SulfoRhodamine B,SRB)染色法对55株来自热带太平洋深海微生物(细菌和霉菌)的培养液的乙酸乙酯抽提物以及菌体的甲醇提取物进行了细胞毒活性筛选,并主要采用分子生物学方法鉴定了该批菌株。结果表明,55株微生物发酵样品共110个提取物中,90%样品表现出细胞毒活性;其中13株微生物的活性较强(提取物有效抑制浓度≤16μg/ml),具有较好的开发应用前景。同时还发现,菌体中检测到的活性菌株数大于发酵液中检测到的活性菌株数,细菌的筛选得率高于霉菌的筛选得率.鉴定结果显示,50株微生物分属于21属、29种,其中13个较高活性菌株来源于8个属。 A total of 110 bio-products, extracted from both the supernatants by ethyl acetate and the precipitated thalli by methanol, derived from the fermented broths of 55 microorganisms including bacteria and molds isolated from deep seas in the tropical Pacific Ocean, were screened for antitumor activity by using 4 human cancer cell lines as the tested models and the techniques of methyl thiazolyl blue tetrazolium bromide (MTT) and sulforhodamine B(SRB) colorimetric assay; while the microbial strains were identified mainly by the molecular biology techniques. Some 90% of the tested 110 extracts appeared antitumor activity and 13 strains of the 55 isolates showed higher inhibitory capacities(effective concerntrations ≤ 16μg/ml), which may imply a possiblility in their further medical application;whereas the percentage of positive extracts was higher from the thalli than that from the supernatants and of actived strains was higher in the bacteria than that in the molds according to this study. The 50 identitied strains belong to 29 species in 21 genera while the 13 higher actived strains distribute in 8 genera. These results probably released a pilot information in the research and development of deep sea microbial resources in China.
出处 《中国生物工程杂志》 CAS CSCD 北大核心 2007年第10期81-86,共6页 China Biotechnology
基金 中国大洋矿产研究开发协会资助项目(DY105-04-02-10)
关键词 深海 热带太平洋 抗肿瘤鉴定 细菌 丝状真菌 Deep-sea Tropical Pacific Ocean Antitumor Identification Bacteria Filamentary fungi
  • 相关文献

参考文献20

  • 1杨春娥,李宏力,高苏莉.抗肿瘤药物临床应用的现状与研究进展[J].国外医药(抗生素分册),2004,25(1):30-33. 被引量:9
  • 2Bugni T S,Ireland C M.Marine-derived fungi:a chemically and biologically diverse group of microorganisms.Nat Prod Rep,2004,21:143-163
  • 3Kelecom A.Secondary metabolites from marine micmorganisms.An Acad Bras Cienc,2002,74(1):151 -170
  • 4赵昌会,叶德赞,魏文铃.深海微生物的研究进展[J].微生物学通报,2006,33(3):142-146. 被引量:20
  • 5党宏月,宋林生,李铁刚,秦蕴珊.海底深部生物圈微生物的研究进展[J].地球科学进展,2005,20(12):1306-1313. 被引量:19
  • 6奥斯伯F 颜自颖等(译).精编分子生物学实验指南(第3版)[M].北京:科学出版社,1998.691-694.
  • 7吴志红,汪天虹,黄卫,曲音波.简便易行的丝状真菌染色体DNA提取法[J].菌物系统,2001,20(4):575-577. 被引量:81
  • 8Gustafson K,Roman M,Fenical W.The macrolactins,a novel class of antiviral and cytotoxic macrolides from a deep-sea marine bacterium.J Am Chem Soc,1989,111:7519 -7524
  • 9Davidson B S,Schumacher R W.Isolation and synthesis of caprolactins A and B,new caprolactams from a marine bacterium.Tetrahedron,1993,49:6569 -6574
  • 10Feling R H,Buchanan G O,Mincer T J,et al.Salinosporamide A:a highly cytotoxic proteasome inhibitor from a novel microbial source,a marine bacterium of the new genus Salinospora.Angewandte Chemie International Edition,2003,42(3):355 -357

二级参考文献65

  • 1许实波.海洋生理活性物质的研究及发展趋势[J].生物工程进展,1996,16(6):25-33. 被引量:22
  • 2刘雪莉,钱伯初.日本海洋天然活性物质研究简况[J].中国海洋药物,1997,16(1):45-49. 被引量:44
  • 3Liu JS, Kuo SR, Mchugh MM, et al. Adozelesin triggers DNA damage response pathways and arrests SV40 DNA replication though replication protein A inactivation [ J ]. J Biol Chem ,2000,275(2) : 1391.
  • 4Awada A, Punt CJ, Piccat MJ, et al. Phase I study of Carzelesin (U-80, 244) given(4- weekly) by intravenous bolus schedule [J]. Br J Cancer, 1999,79(9 - 10) : 1451.
  • 5Armand J P,Seymour L,Evans TR. Rahitrexed in combination with platinum- based agents and/or anthracyclines: preliminary results of phase Ⅰ clinical trials[J ]. Eur J Cancer,1999,35(Suppl 1) :S14.
  • 6Edelman MJ, Gandara DR, et al. Phase I trail of edatrexate plus carboplatin in advanced solid tumors: a melioration of dose- limiting muoositis by ice chip cryotherapy [ J ]. Invest New Drugs, 1998,16( 1 ) :69.
  • 7Ramamathan RK,Lipsitz S,Asbury RF,et al. Phase Ⅱ trail of trimetrexate for patients with advanced gastric carcinoma: an Eastern Cooper active Oncology Group study (E1287) [J ].Cancer, 1999,86(4) :572.
  • 8Igarashi H, Ito T,Ogoshi K, et al. PhaseⅡ trail topically applied miltefosine solution in patients with skin - metastasized breast cancer [J ]. Br J Cancer, 1999,79(7 - 8) : 1158.
  • 9Uehida N, Takeda Y, Kasai H, et al. Antitumor efficacy of nedaplatin, a novel platinum complex, with cyclophosphamide in murine and human tumor mode[J]. Anticancer Res, 1998,18(5A) :3375.
  • 10Raymond E, Charley SG , Taamma A, et al . Oxaliplatin : a review of practical and clinical studies [J]. Ann Oncol, 1998,9(10) : 1053.

共引文献141

同被引文献116

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部